Viewing Study NCT01656018


Ignite Creation Date: 2025-12-25 @ 4:32 AM
Ignite Modification Date: 2026-01-26 @ 9:43 PM
Study NCT ID: NCT01656018
Status: COMPLETED
Last Update Posted: 2016-04-07
First Post: 2012-07-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Safety, Acceptability, Pharmacokinetics, and ex Vivo Pharmacodynamics of TMC278 Long Acting Formulation in HIV-1 Seronegative Participants
Sponsor: Janssen Research & Development, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module